Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 1,098,077 | 1,137,422 | 998,617 | 869,612 | 802,329 |
| Cost of Goods | 110,831 | 109,083 | 88,840 | 83,955 | 59,474 |
| Gross Profit | 987,246 | 1,028,339 | 909,777 | 785,657 | 742,855 |
| Operating Expenses | 756,995 | 636,000 | 565,758 | 503,059 | 527,526 |
| Operating Income | 231,082 | 392,422 | 344,859 | 283,553 | 215,803 |
| Interest Expense | 5,758 | 1,273 | 0 | 7,210 | 6,350 |
| Other Income | 1,965 | 2,140 | -16,863 | 180 | -19,730 |
| Pre-tax Income | 227,289 | 393,289 | 327,996 | 276,523 | 189,723 |
| Income Tax | 72,295 | 182,891 | 133,353 | 200,502 | 99,628 |
| Net Income Continuous | 154,994 | 210,398 | 194,643 | 76,021 | 90,095 |
| Net Income | $154,994 | $210,398 | $194,643 | $76,021 | $90,095 |
| EPS Basic Total Ops | 1.50 | 2.04 | 1.89 | 0.74 | 0.88 |
| EPS Basic Continuous Ops | 1.50 | 2.04 | 1.89 | 0.74 | 0.88 |
| EPS Diluted Total Ops | 1.35 | 1.82 | 1.69 | 0.66 | 0.79 |
| EPS Diluted Continuous Ops | 1.35 | 1.81 | 1.69 | 0.66 | 0.81 |
| EBITDA(a) | $253,992 | $413,096 | $360,157 | $299,580 | $229,938 |